Position in INFU
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$127,949
+$127,948 QoQ
Shares Held
13,259
+7225.4% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 98 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INFU Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $556,179,741 across 31 Medical Devices names. INFU ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
5,343,777 | $228,072,401 | |
| 2 | SYK |
Stryker Corp
|
545,871 | $171,862,025 | |
| 3 | MDT |
Medtronic plc
|
922,752 | $72,186,888 | |
| 4 | DXCM |
Dexcom Inc
|
127,943 | $8,616,961 | |
| 5 | GMED |
Globus Medical Inc
|
103,160 | $8,150,671 | |
| 6 | TMDX |
TransMedics Group, Inc.
|
92,549 | $6,147,104 | |
| 7 | PODD |
Insulet Corp
|
35,853 | $5,458,619 | |
| 8 | LIVN |
LivaNova PLC
|
63,472 | $5,219,302 |
All Filings in INFU
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,949 | 13,259 | Shares | Sole | 2026-08-14 | |
| 2024-09-30 | $1 | 181 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,044 | 153 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $2 | 240 | Shares | Sole | 2024-02-14 | |
| 2021-12-31 | $10,166 | 597 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $7,778 | 597 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $47,172 | 2,269 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $46,196 | 2,269 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $42,611 | 2,269 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $40,280 | 3,142 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||